Modalis Therapeutics Corporation

¥24.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:4883Healthcare
Country Japan
PE (Fwd) •••
TSR 6Y CAGR (55.22%)
Div yield —
ROE (72.15%)
Biotechnology
Beta (5Y) 0.32
PE TTM —
TSR TTM (68.42%)
Mkt cap ¥2.727B
ROIC (44.98%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥25
4.64%
(34.50%)
Hold 7|10|1|0|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.22
0.24
0.23
0.25
3.35%
6.01%
5.33%
15.08%
Revenue¥M
186.5
190.4
186.0
184.2
14.56%
10.84%
2.92%
2.78%
Peers (US$17.32M)
Cap (US$)
PE
20.20M
—
19.27M
15.71x
Capital
TTM
5Y
10Y
Leveragex
0.924
(0.724)
(0.635)
EBIT/Intx
1.085
1.063
0.993
Own earn%
11.48
(5.68)
(5.75)
Sh yield%
25.64
28.18
27.95
Owners
Insiders/Inst%
2.45
66.37
Short interest%
3.19
SBC / revenue%
5.02
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
21–25
$1 testx
—
Incr. ROIC%
9